Western Sweden Systemic Sclerosis Project

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Researchers will enroll a cohort of patients with systemic sclerosis at rheumatology clinics in Gothenburg, Skövde, and Borås. They will collect clinical data and biological samples including blood, skin biopsies, and DNA and apply state-of-the-art molecular and immune profiling. Integrated analyses and in vitro functional studies using patient specimens will be used to identify genes, proteins, metabolites, and immune cell types associated with disease onset and progression. The overall aim is to discover diagnostic or prognostic markers and potential therapeutic targets to inform future care.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Participants diagnosed with SSc according to the ACR and EULAR classification criteria

Exclusion Criteria:

* Diagnosis of Mixed connective tissue disease
* Not speaking or reading Swedish
* With severe cognitive impairment
* With blood count below specified limits
* Allergy to local anaesthetic (for subjects who will provide a skin biopsy)

Where it's running

• Rheumatology clinics, Sahlgrenska University Hospital
  Gothenburg, Sweden, Sweden Recruiting

Study contacts

• Study coordinator: Cristina Maglio, MD, PhD
• Email: cristina.maglio@gu.se
• Phone: 0046 733231485

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Imaging endometriosis with a special PET tracer in adult women

  This study tests whether a PET/CT scan using [18F]AlF-FAPI-74 can help detect endometriosis lesions in women who are planning laparoscopy.

  Recruiting Universitaire Ziekenhuizen KU Leuven · Leuven · NCT07876648

• Inhaled mosliciguat for pulmonary hypertension in interstitial lung disease (PH-ILD) patients

  This study tests inhaled mosliciguat versus placebo in people with PH-ILD to see if it helps with their condition.

  Recruiting at 3 sites Phase 3 Pulmovant, Inc. · Kissimmee, Florida and 2 other locations · NCT07816185

• Skin Color and Sun Damage: Using AI to Classify Pigmentation and Phototype

  Researchers are testing AI-based photo analysis to accurately classify skin pigmentation, phototype, and sun damage in adults to improve skin health risk assessments and care.

  Recruiting at 5 sites Region Skane · Brisbane, Queensland and 12 other locations · NCT07765303

• First-in-human test of PRO-203 in healthy adults and people with systemic sclerosis

  Researchers will test a single subcutaneous dose of PRO-203 in healthy adults and in people with systemic sclerosis to see if it is safe and how the body handles it.

  Recruiting at 12 sites Phase 1/2 Prolium Bioscience, Inc · Melbourne, Victoria and 12 other locations · NCT07641634

• Anti-CD19 CAR T-cell therapy for severe systemic sclerosis that didn’t respond to standard treatment

  This study tests whether a patient’s own anti-CD19 CAR T-cells can help reduce skin thickening and other disease activity in adults with active, treatment-resistant systemic sclerosis.

  Recruiting Phase 2 University Hospital, Montpellier · Lille and 3 other locations · NCT07493395

• Copper supplementation for people with cirrhosis

  This trial will try giving copper supplements to adults with cirrhosis who have low copper levels or signs of copper deficiency to see if liver-related health improves.

  Recruiting University of Washington · Seattle, Washington · NCT07471542

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.